Pembrolizumab versus Methotrexat, Docetaxel oder Cetuximab
Crossref DOI link: https://doi.org/10.1007/s15004-019-6755-y
Published Online: 2019-11-08
Published Print: 2019-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hermann, Robert M.
Christiansen, Hans
Text and Data Mining valid from 2019-11-01
Version of Record valid from 2019-11-01
Article History
First Online: 8 November 2019